Want to Participate in a Clinical Research Trial for Depression?
Fill out this quick Pre-Screening Questionnaire for Depression
- Please complete this form to determine your eligibility for our depression studies
Pre-screening questionnaire and your privacy
Your privacy and confidentiality are our top priorities at Excell Research. By completing the study pre-screening questionnaire, you may be asked to provide personal details such as age, gender, and current medical condition. Rest assured, this information is solely used to assess your eligibility for our ongoing studies at our Oceanside, CA location.
Should you qualify, one of our staff members will reach out to conduct a phone-screening session. Please note that your personal information will be handled with the utmost care and will only be shared with relevant personnel involved in the clinical research study process.
We guarantee that your information will not be sold to third-party companies, and it will not be stored or collected without your explicit consent. Your trust is invaluable to us, and we are committed to maintaining the highest standards of privacy protection throughout your participation in our research studies. Thank you for considering Excell Research.
Many pharmaceutical companies and Excell Research are conducting these studies under the Food and Drug Administration (FDA) to learn more about new investigational drugs or treatments. Read our privacy policy to learn more about how your information will be kept private.
Depression Clinical Research Trials
Depression Clinical Research Trials
Depression Study A
Sponsor: Alto Neuroscience
Protocol Number: ALTO-100-201
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ALTO-100 With an Open-Label Extension in Adults With Major Depressive Disorder
Inclusion Criteria:
- Ages: 18-64
- Have a diagnosis of moderate to severe major depressive disorder (MDD)
- Can stay on an antidepressant medication if taking one.
- Must not be pregnant or breastfeeding at time of enrollment or throughout study
- Reimbursement for time and travel up to $700
Exclusion Criteria:
- Evidence of unstable medical condition
- Diagnosed bipolar disorder, psychotic disorder, or dementia
- Current moderate or severe substance use disorder
- Concurrent or recent participation in another clinical trial for mental illness involving an investigational product or device.
Depression Study B
Sponsor: DeNovo Biopharma LLC
Protocol Number: DB104-01
A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment Resistant Depression
Inclusion Criteria:
- Ages: 18-64
- Have a diagnosis of moderate to severe major depressive disorder (MDD)
- Has tried 2 or more Antidepressants of a different class in the past 5 years.
- Must not be pregnant or breastfeeding at time of enrollment or throughout study
- Reimbursement for time and travel up to $900
Other Clinical Research Trials Available to Participants
Join the forefront of scientific advancement by participating in Excell’s clinical trial studies. Your contribution could lead to groundbreaking treatments for prevalent and challenging diseases and conditions.
At Excell, we prioritize providing transparent and thorough information about the risks and benefits of participation. You’ll receive clear answers to all your inquiries, empowering you to make informed decisions about your health.
Additionally, financial compensation may be available for eligible participants who complete visits for our clinical trial studies.
Take the first step towards making a difference in medical research. Sign up for our clinical trial studies today and play a vital role in shaping the future of healthcare.
Generalized Anxiety Clinical Research Studies
Summary: Generalized Anxiety Disorder and Social Anxiety Disorder clinical trials aim to research investigational therapies for the aforementioned indications. Millions of people suffer from anxiety and it continues to become a growing trend within the general population.
Eligibility Criteria:
Key Inclusion Criteria:
- Male or female subject between 18 to 65 years of age.
- Symptoms of Generalized Anxiety Disorder over the past 6 months.
- Primary focus of treatment is Generalized Anxiety Disorder.
Key Exclusion Criteria:
- Diagnosis other than Generalized Anxiety Disorder that was the primary focus of treatment within 12 months before Screening.
- Previous inadequate response to more than 3 antidepressant treatments.
- Any clinically significant unstable medical condition or any clinically significant chronic disease, that would limit the subject’s ability to complete and/or participate in the study.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18 to 65
Schizophrenia Clinical Research Studies
Summary: Schizophrenia clinical trials explore new treatments and therapies to improve the quality of life for individuals living with the condition. Participants may gain access to cutting-edge care, contribute to medical advancements, and receive compensation for their time. Trials typically involve diagnostic evaluations, medication or therapy protocols, and regular monitoring by medical professionals. Eligibility criteria vary, so interested individuals should consult with the trial coordinators to determine if they qualify.
Eligibility Criteria
Key Inclusion Criteria:
- Experiencing cognitive impairment with a previous diagnosis of Schizophrenia.
- Willing to comply with all study assessments and procedures.
Key Exclusion Criteria:
- Diagnosed with bi-polar disorder or other non-schizophrenic psychotic disorders.
- Current substance/alcohol abuse.
- Clinically significant medical conditions.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18-50
OCD Clinical Research Studies
Summary: OCD clinical trials investigate innovative treatments to help manage obsessive-compulsive disorder symptoms and improve daily functioning. Participants may access new therapies, receive expert care, and often receive compensation. Trials typically include assessments, therapy or medication regimens, and regular follow-ups with specialists. Eligibility varies, so interested individuals should contact trial coordinators to learn more.
Eligibility Criteria:
Key Inclusion Criteria:
- Experiencing moderate to severe symptoms of obsessive-compulsive disorder in the past year.
- Currently taking an SSRI medication for 8 weeks prior to study entry. (Zoloft, Prozac, Lexapro, Celexa, ect.)
- Willing to stop exclusionary psychiatric medications prior to study entry.
Key Exclusion Criteria:
- Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
- Unwilling to discontinue exclusionary medications or comply with study procedures.
- Any clinically significant unstable medical condition or any clinically significant chronic disease.
Patient Time Reimbursed?
Yes
Patient Travel Reimbursed?
Yes
Age:
18 to 65
Resources for Depression
Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Also called major depressive disorder or clinical depression, it affects how you feel, think and behave and can lead to a variety of emotional and physical problems. You may have trouble doing normal day-to-day activities, and sometimes you may feel as if life isn’t worth living.
Symptoms:
Although depression may occur only once during your life, people typically have multiple episodes. During these episodes, symptoms occur most of the day, nearly every day and may include:
- Feelings of sadness, tearfulness, emptiness or hopelessness
- Angry outbursts, irritability or frustration, even over small matters
- Loss of interest or pleasure in most or all normal activities, such as sex, hobbies or sports
- Sleep disturbances, including insomnia or sleeping too much
- Tiredness and lack of energy, so even small tasks take extra effort
- Reduced appetite and weight loss or increased cravings for food and weight gain
- Anxiety, agitation or restlessness
- Slowed thinking, speaking or body movements
- Feelings of worthlessness or guilt, fixating on past failures or self-blame
- Trouble thinking, concentrating, making decisions and remembering things
- Frequent or recurrent thoughts of death, suicidal thoughts, suicide attempts or suicide
- Unexplained physical problems, such as back pain or headaches
